The involvement of deubiquitinases in diseases is still poorly understood. However, it is known that they play a role in various physiological processes, particularly in the case of cancers. <ref>PMID:19007433</ref>
The involvement of deubiquitinases in diseases is still poorly understood. However, it is known that they play a role in various physiological processes, particularly in the case of cancers. <ref>PMID:19007433</ref>
In fact, DUBs have a role in the mechanism involved in histone modification and so have influence on tumor development and progression. For instance, in gastric cancer, DUBs are regulated upwards and DUBs are related to tumor size. <ref>PMID:31897112</ref>
In fact, DUBs have a role in the mechanism involved in [https://en.wikipedia.org/wiki/Histone histone] modification and so have influence on tumor development and progression. For instance, in gastric cancer, DUBs are regulated upwards and DUBs are related to tumor size. <ref>PMID:31897112</ref>
==== Otubain 1 ====
==== Otubain 1 ====
Revision as of 17:59, 23 January 2021
This Sandbox is Reserved from 26/11/2020, through 26/11/2021 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1643 through Sandbox Reserved 1664.
To get started:
Click the edit this page tab at the top. Save the page after each step, then edit it again.
Click the 3D button (when editing, above the wikitext box) to insert Jmol.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.
Deubiquitinating enzymes or Deubiquitinases (DUBs) are enzymes with an ubiquitin-dependent action. More than a hundred DUBs genes exist in humans, making it a very diverse protein and allowing targeted action. Their main role is to cleave ubiquitin bound to a substrate, often a protein. Ubiquitin, bound to the substrate, allows it to regulate its degradation by the proteasome or lysozyme, influences its cellular localisation or modulates the activity with another protein. [1][2]
Deubiquitinases are key enzymes belonging to the vast group of proteases, allowing the degradation of ubiquitin of proteins. These enzymes are thus implicated in the regulation of protein degradation. Indeed, when a protein is going to be degraded, an enzymatic cascade will add a poly-ubiquitin fragment to the protein. This mechanism is called ubiquitination(fr)(en). Following this step, mono or poly-ubiquitin is removed from the protein which has been degraded, by deubiquitinase. [3]
Families
Deubiquitinases belong to the protease family. This family is divided into five classes, according to the nature of the amino acid composition of their active site carrying out the catalysis: serine protease, cysteine proteases, acid proteases, metalloproteases, threonine proteases. DUBs belong to only two of these families: metalloproteases and cysteine proteases.
Among the cysteine proteins, four subfamilies can be described according to their catalytic domains: ubiquitin-specific proteases (USP), les Ubiquitin C-terminal hydrolases (UCH), Otubain proteases (OTU) and Machado-joseph disease proteases (MJD). The deubiquitinases belonging to the family of metalloproteases all have a JAMM catalytic domain (JAB1/MPN/Mov34 metalloenzyme).
Within these two families, DUBs are classified into subfamilies according to the differences in their amino acid sequences surrounding the catalytically active amino acid residues. [4]
Localization
The localization depends on the DUB we consider. However, the majority of DUBs are found in the nucleus, plasma membrane or/and in secretory and endocytic pathways. For example, in the ubiquitin-specific proteases family, the USP21 is mostly associated with microtubules and the centrosome. Thus this deubiquitinase depends on all the physiological mechanisms involving the microtubules. [5]
Structure
The overall structure
3TMP is the catalytic domain of human deubiquitinase DUBA in complex with ubiquitin aldehyde. It is a 8 chain structure with sequence from Human. Indeed, 3TMP is made of these two macromolecules : OTU domain-containing protein 5 (also named DUBA or OTUD5) and Polyubiquitin-C, which is the ubiquitin aldehyde. It is also made of two small molecules which are the phosphoserine (SEP) and the amino-acetaldehyde (GLZ), they are L-peptide links. [6]
Impact of phosphorylation on DUB activity
Evidence shows that phosphorylation influences activity of the enzyme. Phosphorylated serine seems to have the most influence on the activity of the enzyme especially on Ser177. The phosphorylation of this nucleotide is crucial and the protein won't work if it's not.
In fact, this part bends to welcome the protein to be deubiquitinased.
Catalytic domain
It is the catalytic domain which defines the family of the DUB. Indeed, DUBs belonging to the family of cysteine proteases have a catalytic site composed of two or three amino acids (dyads or triads). When the catalytic site is active, it may contain cysteine, histidine, aspartate or asparagine residues. In the case of metalloproteases, the active site is composed of a zinc ion and amino acids such as histidine, aspartate and serine. [7]
The studied structure shows both the catalytic site (in orange) and polyubiquitine in purple.
Residues present in the catalytic site of DUBs are often in a non-functional orientation when the substrate is absent. Thus, when the substrate binds to the catalytic site of the enzyme, the site undergoes rearrangement and takes on a functional conformation. [8] The substrate opens and closes to allow the entry of the protein to be deubiquitinased.
The enzyme take this configuration thanks to many hydrogen bonds around Ser177. This is why Phosphorylation is so important to the function of the enzyme. The phosphate group forms many links between substrate ubiquitin and a segment of the OTU domain. This is rare among the known structures of deubiquitinases. Phosphorylation-driven conformational change ressembles the one of kinases.
Biological role
The role of DUBs is in the ubiquitin pathway. The modifications made by DUBs are post-translational modifications. Thus, DUBs have different functions related to ubiquitin:
A : maturation of ubiquitin. When ubiquitin molecules are synthesized, they are not in free form. Thus, DUBs are essential for the generation of free monomers from precursors. The degradation of precursors is carried out by several DUBs belonging to the USPs class.
B : cleavage between protein and mono-ubiquitin and regulation of the poly-ubiquitin chain. DUBs also have a regulatory activity because they allow the elimination of ubiquitin chains mistakenly conjugated to substrates.
C : cleavage between protein and poly-ubiquitin chain. Once the protein has been degraded by the proteasome or autophagolysosome, DUBs allow the polyubiquitin chain to be separated from the protein.
D : recycling of ubiquitin. Certain deubiquitinases allow the separation of polyubiquitin chains in order to release ubiquitin monomers. [9]
Figure 1 : Role of DUBs in the ubiquitin pathways
Disease
The involvement of deubiquitinases in diseases is still poorly understood. However, it is known that they play a role in various physiological processes, particularly in the case of cancers. [10]
In fact, DUBs have a role in the mechanism involved in histone modification and so have influence on tumor development and progression. For instance, in gastric cancer, DUBs are regulated upwards and DUBs are related to tumor size. [11]
Otubain 1
The enzyme Otubain 1 is a deubiquitinase belonging to the Otubain family of proteases. The role of OTUB1 is not yet clearly defined, some studies show the correlation between tumour growth and OTUB1 while others show no involvement or suppression of the tumour by this enzyme. This suggests that the effects of OTUB1 depend on the stage and the tumour itself. However, the therapeutic targeting of OTUB1 could be used for patients with various tumours, since the enzyme is found in many tissues and has a high level of cell expression. [12]
↑Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science. 2007 Jan 12;315(5809):201-5. doi: 10.1126/science.1127085. PMID:17218518 doi:https://dx.doi.org/10.1126/science.1127085
↑Schnell JD, Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem. 2003 Sep 19;278(38):35857-60. doi: 10.1074/jbc.R300018200. Epub 2003, Jul 14. PMID:12860974 doi:https://dx.doi.org/10.1074/jbc.R300018200
↑Wilkinson KD. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 1997 Dec;11(14):1245-56. PMID:9409543
↑Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207. doi:, 10.1016/j.bbamcr.2004.10.003. PMID:15571815 doi:https://dx.doi.org/10.1016/j.bbamcr.2004.10.003
↑Urbe S, Liu H, Hayes SD, Heride C, Rigden DJ, Clague MJ. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions. Mol Biol Cell. 2012 Mar;23(6):1095-103. doi: 10.1091/mbc.E11-08-0668. Epub 2012, Feb 1. PMID:22298430 doi:https://dx.doi.org/10.1091/mbc.E11-08-0668
↑Huang OW, Ma X, Yin J, Flinders J, Maurer T, Kayagaki N, Phung Q, Bosanac I, Arnott D, Dixit VM, Hymowitz SG, Starovasnik MA, Cochran AG. Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol. 2012 Jan 15;19(2):171-5. doi: 10.1038/nsmb.2206. PMID:22245969 doi:10.1038/nsmb.2206
↑Das C, Hoang QQ, Kreinbring CA, Luchansky SJ, Meray RK, Ray SS, Lansbury PT, Ringe D, Petsko GA. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4675-80. Epub 2006 Mar 13. PMID:16537382
↑Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207. doi:, 10.1016/j.bbamcr.2004.10.003. PMID:15571815 doi:https://dx.doi.org/10.1016/j.bbamcr.2004.10.003
↑Sun J, Shi X, Mamun MAA, Gao Y. The role of deubiquitinating enzymes in gastric cancer. Oncol Lett. 2020 Jan;19(1):30-44. doi: 10.3892/ol.2019.11062. Epub 2019 Nov 7. PMID:31897112 doi:https://dx.doi.org/10.3892/ol.2019.11062
↑Saldana M, VanderVorst K, Berg AL, Lee H, Carraway KL. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer. Endocr Relat Cancer. 2019 Jan 1;26(1):R1-R14. doi: 10.1530/ERC-18-0264. PMID:30400005 doi:https://dx.doi.org/10.1530/ERC-18-0264